Altogether our in vitro and in vivo data in mice and humans point to S1PR2 as an attractive therapeutic target for cerebrovascular protection in stroke and other instances of hypoxic or inflammatory injury in cerebral blood vessels. The gene discussed is S1PR2; the disease is Stroke.